Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Epstein-Peterson ZD, Drill E, Aypar U, Batlevi CL, Caron P, Dogan A, Drullinsky P, Gerecitano J, Hamlin PA, Ho C, Jacob A, Joseph A, Laraque L, Matasar MJ, Moskowitz AJ, Moskowitz CH, Mullins C, Owens C, Salles G, Schöder H, Straus DJ, Younes A, Zelenetz AD, Kumar A. Epstein-Peterson ZD, et al. Among authors: joseph a. Haematologica. 2024 Apr 1;109(4):1149-1162. doi: 10.3324/haematol.2023.282898. Haematologica. 2024. PMID: 37646671 Free PMC article. Clinical Trial.
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Kumar A, Casulo C, Advani RH, Budde E, Barr PM, Batlevi CL, Caron P, Constine LS, Dandapani SV, Drill E, Drullinsky P, Friedberg JW, Grieve C, Hamilton A, Hamlin PA, Hoppe RT, Horwitz SM, Joseph A, Khan N, Laraque L, Matasar MJ, Moskowitz AJ, Noy A, Palomba ML, Schöder H, Straus DJ, Vemuri S, Yang J, Younes A, Zelenetz AD, Yahalom J, Moskowitz CH. Kumar A, et al. Among authors: joseph a. J Clin Oncol. 2021 Jul 10;39(20):2257-2265. doi: 10.1200/JCO.21.00108. Epub 2021 Apr 28. J Clin Oncol. 2021. PMID: 33909449
Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design.
Kumar A, Casulo C, Joffe E, Moskowitz C, Gerecitano J, Moskowitz A, Younes A, Drullinsky P, Drill E, Choma M, Grieve C, Joseph A, Laraque L, Schick D, Zelenetz A, Hamlin P. Kumar A, et al. Among authors: joseph a. Leuk Lymphoma. 2022 Dec;63(12):2889-2896. doi: 10.1080/10428194.2022.2109155. Epub 2022 Aug 16. Leuk Lymphoma. 2022. PMID: 35972020 Clinical Trial.
Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Epstein-Peterson ZD, Drill E, Aypar U, Batlevi CL, Caron P, Dogan A, Drullinsky P, Gerecitano J, Hamlin PA, Ho C, Jacob A, Joseph A, Laraque L, Matasar MJ, Moskowitz AJ, Moskowitz CH, Mullins C, Owens C, Salles G, Schöder H, Straus DJ, Younes A, Zelenetz AD, Kumar A. Epstein-Peterson ZD, et al. Among authors: joseph a. Haematologica. 2024 Aug 1;109(8):2749-2752. doi: 10.3324/haematol.2024.285845. Haematologica. 2024. PMID: 39087412 Free PMC article. No abstract available.
A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma.
Gurumurthi A, Bantilan KS, Hamlin PA, Kumar A, Matasar M, Zhu M, Joseph A, Castro A, Biggar E, Salles G, Zelenetz AD, von Keudell G. Gurumurthi A, et al. Among authors: joseph a. Leuk Lymphoma. 2024 Dec;65(14):2224-2227. doi: 10.1080/10428194.2024.2398658. Epub 2024 Sep 20. Leuk Lymphoma. 2024. PMID: 39303057 No abstract available.
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation.
Kumar A, Soumerai JD, Abramson JS, Barnes JA, Caron PC, Chhabra S, Chabowska M, Dogan A, Falchi L, Grieve C, Haydu JE, Johnson PC, Joseph A, Kelly H, Labarre A, Lue JK, Martignetti R, Mi J, Moskowitz AJ, Owens CN, Plummer S, Puccio M, Salles GA, Seshan VE, Simkins E, Slupe N, Zhang H, Zelenetz AD. Kumar A, et al. Among authors: joseph a. Blood. 2024 Oct 22:blood.2024025563. doi: 10.1182/blood.2024025563. Online ahead of print. Blood. 2024. PMID: 39437708 Free article.
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diarrhoeal Diseases Collaborators. GBD 2021 Diarrhoeal Diseases Collaborators. Lancet Infect Dis. 2024 Dec 18:S1473-3099(24)00691-1. doi: 10.1016/S1473-3099(24)00691-1. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39708822 Free article.
2,407 results